Results 41 to 50 of about 1,761 (189)

Transient Increased Risk of Shingles Post-Shingrix Vaccination: Self-Controlled Case-Series Analysis. [PDF]

Clin Infect Dis
BACKGROUND: Following the introduction of a funded recombinant shingles vaccine (RZV; Shingrix, GlaxoSmithKline) vaccination program in adults aged ≥65 years in Australia, clinician reports of shingles presentations shortly after vaccination emerged.
Shetty AN, Hennessy D, Kattan GS, Ojaimi S, Clothier HJ, Buttery JP.   +5 more
europepmc   +2 more sources

Blistering Eruption on the Subcontinent: The Looming Public Health Threat of Herpes Zoster, ‘Shingles’ in India and the Urgent need for Vaccination

Indian Journal of Community Medicine
Herpes zoster (HZ), or ‘Shingles’, caused by the reactivation of the varicella-zoster virus (VZV), is an emerging public health concern globally. While global data indicate a rising incidence of HZ, India lacks robust epidemiological studies, despite ...
Levin J. Varghese, Amit K. Mishra
doaj   +1 more source

Reduction in Herpes Zoster Antiviral Use Since the Introduction of the Live-Attenuated Zoster Vaccine on Australia’s National Immunisation Program: A Population-Based Study from 1994 to 2019

Infectious Diseases and Therapy, 2023
Introduction Zostavax, the live-attenuated vaccine used to prevent herpes zoster (HZ), has been available to individuals aged 70 and 71–79 years (phased catch-up) via Australia’s National Immunisation Program (NIP) since 2016.
Sachin Phakey, Sophie L. Rogers, Anthony J. Hall, Lyndell L. Lim   +3 more
doaj   +1 more source

Adherence to Herpes Zoster (Shingles) Catch-Up Campaign at the Romagna Local Health Authority (Italy), a Multi-Center Retrospective Observational Study

Vaccines, 2022
Herpes Zoster (shingles) is an infection that occurs when varicella-zoster virus reactivates from the latent state. Incidence and severity of Herpes Zoster disease increase with age.
Andrea Ceccarelli, Susan Scrimaglia, Virginia Fossi, Luigi Ceccaroni, Andrea Federici, Chiara Reali, Raffaella Angelini, Giulia Silvestrini, Francesco Sintoni, Maria Pia Fantini, Davide Gori, Francesca Righi, Marco Montalti   +12 more
doaj   +1 more source

Guideline for the Diagnosis and Management of Heritable IFNAR1 Deficiency in Oceania

Journal of Paediatrics and Child Health, EarlyView.
ABSTRACT Autosomal recessive interferon alpha and beta receptor subunit 1 (IFNAR1) deficiency is a rare and heritable inborn error of immunity (IEI) predisposing individuals to severe and life‐threatening viral infections. It is more common in people of Western Polynesian ancestry, with estimates of around one in six thousand live births affected, due ...
Cecilia Verryt, Paul Gray, Peter McNaughton, Jane Peake, Melanie Wong, George Aho, Emma Best, Maia Brewerton, Flora Lutui, Litara Esera Tulifau, Rebecca Qin, Satupa‘itea Viali, Petine White, Andrew Wood, See‐Tarn Woon, Theresa Cole, Alberto Pinzon Charry, Kuang‐Chih Hsiao   +17 more
wiley   +1 more source

Natural and Synthetic Saponins as Vaccine Adjuvants

Vaccines, 2021
Saponin adjuvants have been extensively studied for their use in veterinary and human vaccines. Among them, QS-21 stands out owing to its unique profile of immunostimulating activity, inducing a balanced Th1/Th2 immunity, which is valuable to a broad ...
Pengfei Wang
doaj   +1 more source

Reactivation of Herpes Zoster After Recombinant Vaccine (Shingrix): A Case Report

Cureus, 2023
Herpes zoster (HZ) is a common contagious dermatological condition that results from reactivation of varicella-zoster virus (VZV), which currently could be prevented by vaccination. We describe a rare case of varicella infection reactivation after routine zoster vaccination in an immunocompetent female in her 60s who developed dermatomal pruritic and ...
Altukhaim, Feras, Mutlaq, May, Alghamdi, Mohammed, Hakami, Salha   +3 more
openaire   +2 more sources

EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation

HemaSphere, Volume 10, Issue 6, June 2026.
Abstract Previous editions of the European guidelines for the management of chronic lymphocytic leukemia (CLL) were developed by experts in CLL under the auspices of the European Society for Medical Oncology (ESMO). These previous editions have served as a reference text for many physicians caring for patients with CLL.
Barbara Eichhorst, Paolo Ghia, Francesc Bosch, Ruth Clifford, Michael Gregor, Romain Guieze, Arnon P. Kater, Carsten U. Niemann, Sarka Pospisilova, Tadeusz Robak, Anna Schuh, Kostas Stamatopoulos, Tamar Tadmor, Nick York   +13 more
wiley   +1 more source

Community Perspectives on Japanese Encephalitis Risk and Prevention in an Endemic Region of Australia

Australian Journal of Rural Health, Volume 34, Issue 3, June 2026.
ABSTRACT Objective Japanese encephalitis (JE) is a mosquito‐borne disease caused by JE virus (JEV) infection, detected for the first time in south‐eastern Australia in 2022. In New South Wales (NSW), detections of JEV in mosquitoes and animal hosts, human JE cases, and climate and environmental considerations have informed which areas are considered ...
Jennifer White, Peter Murray, Megan Vilder, Sharon Saxby, David N. Durrheim   +4 more
wiley   +1 more source

Association of asthma and herpes zoster, the role of vaccination: A literature review

Immunity, Inflammation and Disease, 2022
Herpes Zoster (HZ) is the reactivation of a previous infection with varicella‐zoster virus (VZV) which shares the same mode of transmission as HZ. It presents with painful erythematous vesicles in a dermatome which is characterized by a burning sensation
Abhigan Babu Shrestha, Tungki Pratama Umar, Yasmine Adel Mohammed, Manjil Aryal, Sajina Shrestha, Unnat Hamal Sapkota, Lukash Adhikari, Shumneva Shrestha   +7 more
doaj   +1 more source